TrophoSYS GmbH is pur­su­ing the goal of intro­duc­ing a new process for sex-spe­cific germ cell sep­a­ra­tion in ani­mal breed­ing and thus help­ing to improve the qual­ity of the global food sit­u­a­tion. The com­pany has now closed a Series A financ­ing round worth mil­lions of euros with bm|t as lead investor and other pri­vate investors.